Cardiovascular Systems, Inc. Releasing Late-Breaking ORBIT II Coronary Data at EuroPCR Conference
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will present late-breaking data from its ORBIT II study of coronary artery disease at the 2013 European Association of Percutaneous Cardiovascular Interventions (EuroPCR) conference in Paris, May 21–24, 2013.
Help employers find you! Check out all the jobs and post your resume.
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will present late-breaking data from its ORBIT II study of coronary artery disease at the 2013 European Association of Percutaneous Cardiovascular Interventions (EuroPCR) conference in Paris, May 21–24, 2013.
Help employers find you! Check out all the jobs and post your resume.